RE: Distressed placing15 Oct 2022 20:11
Christ. Do you have any actual sources? You’re making a complete prick out of yourself. Have a read of results and brace yourself for data read out. Results are imminent. That’s a fact. Well over a year into trials, orphan status, dose over double the standard, market for dox at 1.5bn at the low end before ava6000 completed trials and it grows. Platform proven by these trials opening up a pipeline of countless Pro-drugs including 3996, now pre clinical. That’s before TMAC etc. Theres nothing distressed about Avacta. It will be worth billions. Suck it up and put your gumshield in. What are the losses when we hit £3? £10? £200 ex chin-ah. You’re all getting buried.